JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs

Project Details

Short titleJAK2 Inhibitoren
StatusActive
Effective start/end date01.01.202231.12.2024

Collaborative partners

Funding

  • Gesellschaft für Forschungsförderung NÖ